{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:22:19Z","timestamp":1790652139069,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Vector Borne Dis"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/0972-9062.302030","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T13:01:17Z","timestamp":1607000477000},"page":"288","source":"Crossref","is-referenced-by-count":10,"title":["Global scenario of counterfeit antimalarials: A potential threat"],"prefix":"10.4103","volume":"56","author":[{"given":"Taruna","family":"Arora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0972-9062.302030-1","first-page":"1019","volume-title":"Counterfeit and substandard antimalarial drugs in Cambodia","author":"Lon","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/0972-9062.302030-2","first-page":"10","volume-title":"Trust and the regulation of pharmaceuticals: South Asia in a globalised world","author":"Brhlikova","year":"2011","journal-title":"Glob Health"},{"key":"key-10.4103\/0972-9062.302030-3","first-page":"209","volume-title":"The counterfeit anti-malarial is a crime against humanity: A systematic review of the scientific evidence","author":"Karunamoorthi","year":"2014","journal-title":"Malar J"},{"key":"key-10.4103\/0972-9062.302030-4","first-page":"352","volume-title":"Poor quality vital anti-malarials in Africa: An urgent neglected public health priority","author":"Newton","year":"2011","journal-title":"Malar J"},{"key":"key-10.4103\/0972-9062.302030-5","first-page":"804","volume-title":"Characterization of counterfeit artesunate antimalarial tablets from southeast Asia","author":"Hall","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0972-9062.302030-6","first-page":"e3403","volume-title":"A nationwide survey of the quality of antimalarials in retail outlets in Tanzania","author":"Kaur","year":"2008","journal-title":"PLoS One"},{"key":"key-10.4103\/0972-9062.302030-7","first-page":"22","volume-title":"Quality of anti-malarial drugs provided by public and private healthcare providers in south-east Nigeria","author":"Onwujekwe","year":"2009","journal-title":"Malar J"},{"key":"key-10.4103\/0972-9062.302030-8","unstructured":"Bernstein I. Drug supply chain security act. Edn 2017; New Hampshire Ave: USFDA. p. 331-56."},{"key":"key-10.4103\/0972-9062.302030-9","first-page":"1241","volume-title":"Fake antimalarials in Southeast Asia are a major impediment to malaria control: Multinational cross-sectional survey on the prevalence of fake antimalarials","author":"Dondorp","year":"2004","journal-title":"Trop Med Int Health"},{"key":"key-10.4103\/0972-9062.302030-10","first-page":"127","volume-title":"Post-marketing surveillance of antimalarial medicines used in Malawi","author":"Chikowe","year":"2015","journal-title":"Malar J"},{"key":"key-10.4103\/0972-9062.302030-11","first-page":"e2012027","volume-title":"The tragedy caused by fake antimalarial drugs","author":"Ambroise-Thomas","year":"2012","journal-title":"Mediterr J Haemato Infect Dis"},{"key":"key-10.4103\/0972-9062.302030-12","first-page":"245","volume-title":"Molecular epidemiology of malaria in Cameroon.XIX: Quality of antimalarial drugs used for self-medication","author":"Basco","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0972-9062.302030-13","first-page":"1179","volume-title":"Quality of artesunate tablets sold in pharmacies in Kumasi, Ghana","author":"Ofori-Kwakye","year":"2008","journal-title":"Trop J Pharmac Res"},{"key":"key-10.4103\/0972-9062.302030-14","first-page":"559","volume-title":"The quality of sulphadoxine pyrimethamine and amodiaquine products in the Kenyan retail sector","author":"Amin","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"key-10.4103\/0972-9062.302030-15","first-page":"68","volume-title":"Quality control of active ingredients in artemisinin derivative antimalarials within Kenya and DR Congo","author":"Atemnkeng","year":"2007","journal-title":"Trop Med Int Health"},{"key":"key-10.4103\/0972-9062.302030-16","unstructured":"Smine A, Diouf K, Blum N. Antimalarial drug quality in Senegal. United States Agency for International Development 2002. Available from: http:\/\/pdf.usaid.gov\/pdf_docs\/PNACW987.pdf (Accessed on October 1, 2018). p. 8."},{"key":"key-10.4103\/0972-9062.302030-17","first-page":"108","volume-title":"Quality of antimalarial drugs in Sudan: Results of post-marketing surveillance","author":"Alfadl","year":"2006","journal-title":"Sudanese J Public Health"},{"key":"key-10.4103\/0972-9062.302030-18","first-page":"575","volume-title":"The chemical and pharmaceutical equivalence of sulphadoxine\/pyrimethamine tablets sold on the Tanzanian market","author":"Hebron","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"key-10.4103\/0972-9062.302030-19","first-page":"488","volume-title":"Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa","author":"Nayyar","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/0972-9062.302030-20","first-page":"e6003","volume-title":"Pilot study of essential drug quality in two major cities in India","author":"Bate","year":"2009","journal-title":"PLoS One"},{"key":"key-10.4103\/0972-9062.302030-21","first-page":"488","volume-title":"The need for better data about counterfeit drugs in developing countries: A proposed standard research methodology tested in Chennai, India","author":"Seear","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"key-10.4103\/0972-9062.302030-22","first-page":"e7270","volume-title":"Simple field assays to check quality of current artemisinin-based antimalarial combination formulations","author":"Ioset","year":"2009","journal-title":"PloS One"},{"key":"key-10.4103\/0972-9062.302030-23","first-page":"51","volume-title":"Substandard antimalarials available in Afghanistan: A case for assessing the quality of drugs in resource poor settings","author":"Lalani","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0972-9062.302030-24","unstructured":"Artemisinin resistance and artemisinin-based combination therapy efficacy: Status report. Geneva: World Health Organization 2018. Available from https:\/\/apps.who.int\/iris\/handle\/10665\/274362 (Accessed on October 2, 2018). p. 10."},{"key":"key-10.4103\/0972-9062.302030-25","first-page":"498","volume-title":"Therapeutic efficacy of artemether\u2013lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India","author":"Bharti","year":"2016","journal-title":"Malar J"}],"container-title":["Journal of Vector Borne Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:50:27Z","timestamp":1786733427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0972-9062.302030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"alternative-id":["302030"],"URL":"https:\/\/doi.org\/10.4103\/0972-9062.302030","relation":{},"ISSN":["0972-9062"],"issn-type":[{"value":"0972-9062","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}